Assignee profile
Gluetacs Therapeutics Shanghai
Coverage of patents, compounds and activity records linked to this assignee.
15 patents3,148 compounds15,262 activity records
Summary
AssigneeGluetacs Therapeutics Shanghai
Filing years2022-2025
Patents15
Compounds3,148
Activity records15,262
Patent families14
Targets26
Assay familiesbiochemical, cellular_function, degradation, unknown, viability
Activity metricsIC50, degradation, inhibition, percent_degradation, percent_inhibition
Overview
Target distribution and active-compound trend
Target distribution
18,559 activity records
Active compounds by publication year
Distinct compounds linked to assignee patent publications
Activity compounds and values